SATORI PHARMACEUTICALS INC

Profile

Company Names

SATORI PHARMACEUTICALS INC

Addresses

281 ALBANY STREET, CAMBRIDGE, MA 02139

75 ROGERS STREET, CAMBRIDGE, MA 02142

Phone Numbers

6175470661
6175470022

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$22,315,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2012-02-10 
$15,000,000.00 
$19,200,000.00 
$4,200,000.00 
Debt 
2
2010-12-22 
$7,000,000.00 
$20,670,000.00 
$13,670,000.00 
Equity 
1
2010-03-22 
$315,000.00 
$315,000.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRIS 
 
EHRLICH 
DIRECTOR
BIOMIMETIC THERAPEUTICS, INC.   |  QUATRX PHARMACEUTICALS CO   |  INVUITY, INC.   |  SATORI PHARMACEUTICALS INC   |  CARBYLAN BIOSURGERY, INC   |  CERO THERAPEUTICS HOLDINGS, INC.
CHRISTOPHER 
 
EHRLICH 
DIRECTOR
SATORI PHARMACEUTICALS INC   |  FOLLICA, INC
STEVEN 
 
HOLTZMAN 
DIRECTOR
SATORI PHARMACEUTICALS INC   |  SHORELINE BIOSCIENCES, INC.   |  MANIFOLD BIOTECHNOLOGIES, INC.   |  SOMITE THERAPEUTICS, INC.
JEFFREY 
 
IVES 
EXECUTIVE OFFICER, DIRECTOR
SATORI PHARMACEUTICALS INC   |  ASTROCYTE PHARMACEUTICALS INC.
EDWARD 
 
MATHERS 
DIRECTOR
RA PHARMACEUTICALS, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  SATORI PHARMACEUTICALS INC   |  MIRNA THERAPEUTICS, INC.   |  RHYTHM HOLDING COMPANY, LLC   |  LUMENA PHARMACEUTICALS, INC.   |  LUMOS PHARMA, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  LIQUIDIA TECHNOLOGIES INC   |  INOZYME PHARMA, INC.   |  SYNLOGIC, INC.   |  AFFINIA THERAPEUTICS INC.   |  CODE BIOTHERAPEUTICS, INC.   |  TREVI THERAPEUTICS, INC.   |  SORRISO PHARMACEUTICALS, INC.   |  MBX BIOSCIENCES, INC.   |  CARDURION PHARMACEUTICALS, INC.   |  BRENIG THERAPEUTICS, INC.   |  SENTI BIOSCIENCES, INC.   |  SENTI BIOSCIENCES HOLDINGS, INC.   |  SENTI HOLDINGS, INC.   |  SENTI BIOSCIENCES, INC.
STEPHEN 
 
MUNIZ 
DIRECTOR
KARUNA PHARMACEUTICALS INC   |  SATORI PHARMACEUTICALS INC
DAVID 
 
SCHNELL 
DIRECTOR
GLOUCESTER PHARMACEUTICALS INC   |  LUX BIOSCIENCES INC   |  NORA THERAPEUTICS, INC.   |  TRUBION PHARMACEUTICALS, INC   |  NGM BIOPHARMACEUTICALS INC   |  KYTHERA BIOPHARMACEUTICALS INC   |  SATORI PHARMACEUTICALS INC   |  ALVINE PHARMACEUTICALS INC   |  AJAX THERAPEUTICS, INC.
BENNETT 
 
SHAPIRO 
DIRECTOR
SATORI PHARMACEUTICALS INC   |  VEDANTA BIOSCIENCES, INC.
ILAN 
 
ZIPKIN 
DIRECTOR
ALVINE PHARMACEUTICALS INC   |  CHIMEROS INC   |  SATORI PHARMACEUTICALS INC   |  CORTEXYME, INC.   |  BIONIZ THERAPEUTICS, INC.   |  VIA NOVA THERAPEUTICS, INC.
DAPHNE 
 
ZOHAR 
DIRECTOR
SATORI PHARMACEUTICALS INC   |  FOLLICA, INC   |  KARUNA PHARMACEUTICALS INC   |  TAL MEDICAL INC.   |  SEAPORT THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-02-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-10 
2011-01-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-22 
2010-04-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2010-03-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#